Introduction
Attention-Deficit/Hyperactivity Disorder (ADHD) is a developmental disorder where all clinical criteria are behavioral. It is a heterogeneous disorder affecting about 5% of children (Faraone and Mick 2010) and its prevalence is similar in different cultures (Dwivedi and Banhatti 2005; Meyer et al. 2004; Rohde et al. 2005) . The heterogeneity may be sorted along two independent behavioral dimensions: inattention and hyperactivity-impulsiveness (Lahey and Willcutt 2010) . DSM-IV (American Psychiatric Association 2000) attempts to reduce the heterogeneity by subdividing ADHD into three subtypes: the predominantly inattentive subtype of ADHD (ADHD-I); the predominantly hyperactive-impulsive subtype (ADHD-H) and the combined subtype of Attention Deficit/Hyperactivity Disorder (ADHD-C). ADHD places the child at increased risk of school failure, juvenile delinquency, criminality, 5 substance abuse and HIV/AIDS as a consequence of sexual promiscuity and disregard for preventative measures (Barkley et al. 2004; Molina et al. 2002; Kahn et al. 2002) .
There have been many attempts to explain the origins of ADHD symptoms. A learning-theory perspective is gaining ground for the case of ADHD-C. The dynamic developmental theory of ADHD (Johansen et al. 2002; Johansen et al. 2009; Sagvolden et al. 2005a; Johnson et al. 2009; Sagvolden and Archer 1989) suggests that less efficient dopamine-mediated reinforcement processes and deficient extinction of previously reinforced behavior may explain behavioral changes that are often described as either poor 'executive functions' (Tannock 1998) or as 'response disinhibition' (Barkley 1997) . This learning-theory perspective predicts specific neuronal changes related to synaptic plasticity and long-term potentiation (LTP) ).
A reinforcer is not defined in terms of previous events, but in terms of the behavioral changes that follow the reinforcer. For a reinforcer to alter behavior, events need to occur within a limited time-frame, but the duration of this time-frame also depends on attentional and memory variables. This is important both in basic laboratory research, where it is often overlooked, and in analysis of ADHD, which is associated with poor attention and memory (Martinussen et al. 2005; Willcutt et al. 2005 ).
Animal models are helpful in medical research ). There are many putative animal models of ADHD (Roessner et al. 2010; Pardey et al. 2009; Sagvolden et al. 2009; Vendruscolo et al. 2009; Sanabria and Killeen 2008; DasBanerjee et al. 2008; Heal et al. 2008; Kostrzewa et al. 2008) . However, it is important to emphasize that the DSM-IV definition of ADHD does not say ''always hyperactive''. Thus, although several molecular 6 and genetic manipulations may produce hyperactive animals (Vendruscolo et al. 2009; Ruocco et al. 2009; Yan et al. 2009; Dalley et al. 2009; Kostrzewa et al. 2008 ), hyperactivity alone is insufficient for the animal to qualify as a model of ADHD. It is important to consider whether children with ADHD would be hyperactive in a similar test or situation ). 
Criteria for a valid animal model of ADHD
Because the diagnosis of ADHD is based on behavior, the validation of animal models must also be based on behavior. If valid animal models were to be found, one would expect many of the same fundamental genetic and neurobiological alterations to be common in the human and the animal case. Thus, an ADHD animal model should mimic the fundamental behavioral characteristics of ADHD (face validity), conform to a theoretical rationale (construct validity), and predict correlates of ADHD in humans as regards behavior, genetics and neuronal 7 functions not shown previously in clinical settings (predictive validity) (Sagvolden 2000; Sagvolden et al. 2009 ). Although a variety of rat and mouse strains exhibit hyperactivity (Russell et al. 2005) , few meet the complete set of criteria for model validation.
Behavioral differences among strains of rats
The SHR displays the major symptoms of ADHD (inattention, hyperactivity and impulsivity) that, like ADHD, develop over time when reinforcers are infrequent (Li et al. 2007 ; van den Bergh et al. 2006; Sagvolden 2000; Johansen et al. 2005b; Sagvolden et al. 2005b; Sagvolden et al. 1998) . As in children with ADHD (Sonuga-Barke et al. 1992) , SHRs are more sensitive to delayed reinforcement Johansen et al. 2005b ), consistent with a steepened delay-of-reinforcement gradient found in SHR relative to controls (Johansen et al. 2007 ). This means that a reinforcer has to be given immediately following the correct behavior in order to be efficient in the SHR while reinforcers could be delayed somewhat in controls and still affect behavior. In addition, as in children with ADHD (Castellanos et al. 2005; , there is increased intra-individual variability and variability in the individual SHR 's behavior within the task, relative to controls (Perry et al. 2010a; Perry et al. 2010b ).
There is systematic overactivity, impulsiveness and sustained attention deficit in the 
Genetic differences among strains
To investigate whether SHR/NCrl rats show changes in expression in systems relevant to ADHD, we have analyzed ADHD candidate genes identified as a part of the International Multi-center ADHD Gene project (IMAGE), and their biological neighbors (collectively referred to as IMAGE genes) (Kuntsi et al. 2006) . The IMAGE gene biological neighbors are defined as any gene that was part of the same gene or protein family as an IMAGE gene, or has a well-established direct relationship with an IMAGE gene.
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The SHR/NCrl rats showed significant changes in a set of IMAGE genes: a number of these genes are relevant for a learning-theory perspective of ADHD-C. The dynamic developmental theory of ADHD Sagvolden et al. 2005a; Johnson et al. 2009; Sagvolden and Archer 1989) suggests that defective interactions between dopamine and glutamate alter synaptic plasticity and long-term potentiation (LTP). On a behavioral level, such a faulty interaction may give rise to less efficient dopamine-mediated reinforcement processes and deficient extinction of previously reinforced behavior, and these differences could explain both inattention and overactivity-impulsiveness associated with ADHD ).
Some of these genes showed decreased expression across tissues in ~65-day-old SHR/NCrl rats compared with WKY/NHsd rats: these included the ionotropic glutamate NMDA binding protein (Grina), the NMDA-like 1A complex (Grinl1a); the NR2D subunit (Grin2d); the AMPA receptor subunit GluR-3 (Gria3); the alpha stimulating, olfactory type guanine nucleotide binding protein (Gnal/Golf); the norepinephrine transporter NET (Slc6a2); calmodulin 3 (Calm3); calcium/calmodulin-dependent protein kinases Camk1, Camk2a, and Camk2g); synaptotagmin III (Syt3); and syntaxin binding protein 1 (Stxbp1). Gnal (Golf) is coupled to the dopamine receptor, DRD1, and plays a major role in excitatory dopamine transmission in the striatum. Significant relationships have been observed between certain SNPs in Gnal and symptoms of inattention and hyperactivity/impulsivity in ADHD children (Laurin et al. 2008 ).
In contrast, other genes showed increased expression (mRNA) in the SHR/NCrl rats compared to WKY/NHsd rats: these included the AMPA receptor subunit Glu-R2 subunit Based on blood samples, no between-strain differences in DNA were observed for either the DRD2 or DRD4 genes, suggesting that neither gene is likely to mediate the behavioral differences between the WKY and SHR strains. In contrast, WKY/SHR differences were observed in the 3rd exon of DAT1. Whilst these mutations do not result in direct amino-acid changes to the DAT protein, it is possible that they mediate some other process that explains the differences in DAT expression and function in the two strains (Mill et al. 2005 ).
The dopamine receptor (DRD1)-interacting protein (DRD1ip), calcyon, represents a brain-specific protein involved in DRD1/DRD5 receptor-mediated calcium signaling. In our data, the SHR/NCrl had a two-fold increase in expression of calcyon mRNA compared with WKY/NHsd rats. This is in agreement with a recent study which examined calcyon mRNA expression in the frontal-striatal circuitry of 3-, 5-, and 10-week-old SHR and WKY rats (Heijtz et al. 2007) . Such a changed expression of DRD1ip may indicate an underlying disruption of reinforcement processes mediated by dopamine (Schultz 2010) .
A major function of dopaminergic transmission is to modulate fast, ionotropic synaptic transmission mediated by the neurotransmitter glutamate. Thus, the observed changes in gene expression for subunits of both AMPA and NMDA glutamatergic receptors may profoundly affect neuronal function. Electrophysiological studies revealed two potential consequences of such changes ). Firstly, in male SHR/NCrl and WKY/NHsd rats, at postnatal day 28, the AMPA receptor-mediated transmission at the CA3-to-CA1 synapses was reduced in the stratum radiatum of the hippocampus. Secondly, the NMDAR containing Grin2b (aka GluN2B) subunits contributed substantially to induction of long-term potentiation in SHR/NCrl, but not in WKY/NHsd. In human ADHD, there is evidence for genetic polymorphism of both Grin2a and Grin2b subunits of the NMDA receptor (Turic et al. 2004; Dorval et al. 2007 ), which might mean that synaptic plasticity associated with learning, reinforcement and extinction may be altered in ADHD individuals as well ).
Human and animal data indicate that the mu opioid receptor 1 (Oprm1) is associated with substance abuse disorders (Berrendero et al. 2002; Zhang et al. 2006) . Individuals with ADHD show strong substance dependence (Faraone et al. 2007 ). Thus, it is possible that substance dependence in ADHD may be modulated by Oprm1.
Applying validity criteria to animal research
A large number of studies support the use of SHR as the best animal model of ADHD.
However, there are also researchers who question the validity of the SHR/NCrl model (Ferguson and Cada 2003; van den Bergh et al. 2006) . This section highlights a few important factors that may have contributed to some of the inconsistencies in the literature regarding the value of SHR as an animal model of ADHD.
WKY heterogeneity: SHR/NCrl and WKY/NCrl versus WKY/NHsd controls
From a genetic point of view, the best candidate for a control strain is the progenitor strain of SHR/NCrl: i.e., the WKY. However, the various WKY substrains are not equally suited to serve as controls due to genetic and behavioral differences. . It is conceivable; however, that inattention is a phenomenon by itself and not necessarily associated with ADHD. Then, the WKY/NCrl might not be a model of ADHD, but of some other disorder mainly associated with inattention.
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Independent of whether or not the WKY/NCrl is a model of ADHD, the heterogeneity between the WKY substrains makes it imperative that researchers provide information about the substrain and breeder used in their studies to enable empirical findings to be adequately evaluated by others.
ADHD: defining features and situational factors
One issue that might lead to disagreement regarding the validity of SHR/NCrl as an animal model of ADHD is how findings are interpreted and extrapolated. A defining feature of ADHD-C and of ADHD-H is hyperactivity. However, the DSM-IV definition of ADHD does not say "always hyperactive", but includes statements like "have persisted for at least 6 months to a degree that is maladaptive and inconsistent with the developmental level" or "present in more than two or more settings". Some animal researchers seem to assume that ADHD is characterized by hyperactivity. Thus, if hyperactivity is not found in the animal model (in the specific test used in the present study), it is not a valid model of ADHD. These researchers fail to ask an additional, central question: "Are children with ADHD always hyperactive?" The answer to that question is "no" based on findings reported in the research literature, clinical experience, and reports from parents and teachers.
As in people with ADHD, the degree of behavioral problems in SHR depends on the task. Thus, the conclusion that a particular animal model is not valid for studies of ADHD, based on results from one test, only, may simply be incorrect. This point emphasizes the importance of good, reliable, translational tests that can be used in the animal model as well solely on one such measure may be erroneous.
Age and development
The lack of a positive response to medication is a final issue that sometimes is used as an argument against the SHR/NCrl model of ADHD. As the greater majority of patients with ADHD do respond positively, an animal model of ADHD should do the same. However, a positive response to medication is not a defining feature of ADHD: up to one in five children diagnosed with ADHD will similarly not respond positively (Faraone and Buitelaar 2010) .
Several studies find that psychostimulants improve symptoms of inattention, hyperactivity and impulsivity in SHR/NCrl (Sagvolden et al. 1992; Wultz et al. 1990; Myers et al. 1982; Sagvolden and Xu 2008) . When some researchers do not find ameliorating effects of medication in SHR/NCrl, it is important to consider whether the behavioral measures are improved by medication in children with ADHD. Further, we may need to adopt a developmental perspective. The effect of psychostimulant treatment in young and adolescent individuals may not be the same as in adults; medication may interact with brain development and neuronal pruning to produce its effects (Shaw et al. 2009; Bizot et al. 2007 ).
In this developmental perspective, we examined the expression of genes involved in dopamine signaling and metabolism in the dorsal striatum and ventral mesencephalon of SHR/NCrl and WKY/NCrl, as well as three reference control strains (WKY/NHsd, WK/HanTac, and SD/NTac) using quantitative real time RT-PCR. In addition, we determined striatal dopamine transporter (DAT) density, by ligand binding assay, in the two ADHD-like strains at different developmental stages and after methylphenidate treatment. In adult rats, the mRNA expression of DAT and tyrosine hydroxylase was elevated in SHR/NCrl and WKY/NCrl rats compared to control strains: differences in DAT and tyrosine hydroxylation expression between SHR/NCrl and WKY/NCrl rats were also evident. During normal development, changes in striatal DAT densities occurred in both strains, with lower densities in WKY/NCrl than SHR/NCrl after postnatal day 25. Two-weeks of methylphenidate treatment, during different developmental stages, was associated with decreased striatal DAT density in both rat strains compared to the non-treated rats with more pronounced effects followed prepubertal treatment (Roessner et al. 2010 (Fuemmeler et al. 2010 ).
Implications for understanding ADHD
The dynamic developmental theory of ADHD Sagvolden et al. 2005a) suggests that reduced dopaminergic transmission changes fundamental behavioral selection mechanisms. This arises from deficient reinforcement of successful behavior, combined with deficient extinction (elimination) of unsuccessful behavior. In SHR/NCrl, neurobiological evidence for such factors is found both in the reduced dopamine efficacy Roessner et al. 2010 ) and in altered long-term potentiation in hippocampal slices ).
Such deficient selection mechanisms will slow the association ('chunking') of simple response units into longer, more elaborate chains of adaptive behavioral elements that function as higher-order behavioral units (Miller 1956; Aase and Sagvolden 2005; Perry et al. 2010a; Perry et al. 2010b) . Whenever behavioral units are chunked together into a chain of responses that is emitted in this context, each behavioral unit reliably precedes the next with high predictability. Consequently, deficient or slowed chunking of behavior will increase intra-individual variability. This is observed in children with ADHD and in the SHR Johansen et al. 2009; Perry et al. 2010a; Perry et al. 2010b ).
Conclusions
There are no obvious behavioral differences amongst the various SHRs, but there are behavioral and neurobiological differences amongst the WKY strains. Several strains of rats may behave like WKY/NHsd rats, genetic studies indicate significant differences between various 'normal' strains. Thus, Sprague Dawley rats may be a poor control for the SHR/NCrl, particularly in neurobiological studies. Given that the Wistar WH/HanTac rats and WKY/NCrl deviate both genetically and behaviorally from the WKY/NHsd, the use of these strains as controls for SHRs may produce spurious neurobiological differences. Thus, WKY/NHsd is the most appropriate control for SHR/NCrl. As a consequence, data may be misinterpreted if researchers or readers do not pay attention to the strain or substrain that was used in a study.
It is likely that lack of attention to such factors has led to erroneous conclusions in studies involving the SHR, WKY and other comparison strains, in model studies of ADHD.
The SHR/NCrl is the best validated animal model of ADHD. Genetic and neurobiological data strengthen such a conclusion. Recent data suggest that the WKY/NCrl is inattentive, but it is unclear whether this substrain can be used as a model of ADHD.
The availability of validated ADHD animal models has substantial implications for research. Unlike some disorders, such as schizophrenia or bipolar disorder (for which there exist brain tissue resource centers) brain tissue is not available for ADHD patients. Animal models provide a source of such tissue for studies of gene expression, epigenetics, neuroanatomy, cellular neurophysiology and other methods. Animal models of ADHD can also be used to search for ADHD genes using linkage or association analysis and to search for gene-environment interactions by exposing susceptible animals to environmental toxins (e.g., polychlorinated biphenyls) suspected to be risk factors for ADHD Holene et al. 1998; Kuehn 2010) . The SHR/NCrl is clearly useful for these.
